Stallion India Fluorochemicals Posts Robust Q2 and H1 FY27 Performance
Stallion India Fluorochemicals Ltd · Press Release · 17 Nov 2026, 12:23 am
Stallion India Fluorochemicals Posts Robust Q2 and H1 FY27 Performance Stallion India Fluorochemicals reported a 31.79% YoY increase in Q2 FY27 total revenue to ₹13,937.33 lakh, with operating EBITDA up 0.43% YoY to ₹1,583.54 lakh and operating PAT growing 4.78% YoY to ₹1,196.21 lakh. For H1 FY27, revenue climbed 22.07% YoY to ₹26,404.90 lakh, while operating EBITDA and operating PAT surged 36.39% YoY to ₹4,110.32 lakh and 40.16% YoY to ₹3,052.78 lakh, respectively (excluding a non-cash ESOP charge of ₹950.92 lakh). Strategically, its Khalapur high-purity Helium facility became operational, alongside ongoing Mambattu, R-32, and HFO expansion projects.
Original exchange filing (PDF)
More announcements from Stallion India Fluorochemicals Ltd
- Intimation regarding Q2 & H1 FY 2026-27 Earnings Conference Call · 19 Nov 2026
- As per attachment. · 16 Nov 2026
- As per the attachment. · 15 Nov 2026
- As per the attachment. · 14 Nov 2026
- Stallion India Fluorochemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
- Outcome of Board Meeting held on 13th November, 2026 - Approval of Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026. · 13 Nov 2026
- Stallion India Fluorochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve As per attachment. · 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 13 Nov 2026
